INCOME STATEMENT
Concord Biotech Ltd.
BSE
Jun 13
2110.55
+50.30 (+ 2.44%)
Volume
4844
Prev. Close
2060.25
Open Price
2019.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 13
2109.70
+46.10 (+ 2.23%)
Volume
166986
Prev. Close
2063.60
Open Price
2010.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE338H01029
|
Market Cap. ( ₹ in Cr. )
|
22070.88
|
P/BV
|
13.88
|
Book Value ( ₹ )
|
152.02
|
|
BSE Code
|
543960
|
52 Week High/Low ( ₹ )
|
2664/1345
|
FV/ML
|
1/1
|
P/E(X)
|
59.39
|
|
NSE Code
|
CONCORDBIOEQ
|
Book Closure
|
29/06/2024
|
EPS ( ₹ )
|
35.52
|
Div Yield (%)
|
0.51
|
(₹ in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 |
| | | | |
| | | | |
| INCOME | | | |
| Revenue From Operations [Net] | 1200.09 | 998.06 | 830.63 |
| Other Operating Revenues | 0.00 | 18.88 | 22.54 |
| Total Operating Revenues | 1200.09 | 1016.94 | 853.17 |
| | | | |
| Other Income | 44.45 | 33.78 | 35.31 |
| Total Revenue | 1244.53 | 1050.72 | 888.48 |
| | | | |
| EXPENSES | | | |
| Cost Of Materials Consumed | 264.31 | 184.54 | 167.07 |
| Purchase Of Stock-In Trade | 55.99 | 56.74 | 28.77 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -14.79 | -12.08 | -15.63 |
| Employee Benefit Expenses | 138.93 | 123.05 | 110.28 |
| Finance Costs | 0.53 | 2.55 | 4.51 |
| Depreciation And Amortisation Expenses | 54.37 | 53.59 | 54.03 |
| Other Expenses | 249.31 | 233.14 | 219.39 |
| Total Expenses | 748.66 | 641.53 | 568.42 |
| | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 495.88 | 409.19 | 320.05 |
| | | | |
| Profit/Loss Before Tax | 495.88 | 409.19 | 320.05 |
| | | | |
| Tax Expenses-Continued Operations | | | |
| Current Tax | 122.91 | 99.83 | 79.53 |
| Deferred Tax | 0.00 | 4.63 | 2.38 |
| Tax For Earlier Years | 0.00 | 0.00 | 0.02 |
| Total Tax Expenses | 122.91 | 104.46 | 81.93 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 372.96 | 304.73 | 238.13 |
| | | | |
| Profit/Loss From Continuing Operations | 372.96 | 304.73 | 238.13 |
| | | | |
| Profit/Loss For The Period | 372.96 | 304.73 | 238.13 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| EARNINGS PER SHARE | | | |
| Basic EPS (Rs.) | 35.65 | 29.13 | 22.76 |
| Diluted EPS (Rs.) | 35.65 | 29.13 | 22.76 |
| | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | |
| Equity Share Dividend | 0.00 | 71.45 | 53.56 |
| Equity Dividend Rate (%) | 1070.00 | 875.00 | 683.00 |